BELITE BIO INC - ADR (BLTE:NASDAQ)
$173.79 -1.28 (-0.7311%)
Analysed BELITE BIO INC - ADR (BLTE:NASDAQ) News Sources
Belite Bio to Participate in the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference
15-07-2026
yahoo.com
Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results
06-08-2026
yahoo.com
Belite Bio Announces U.S. Food and Drug Administration Acceptance and Priority Review of New Drug Application for Tinlarebant for the Treatment of Stargardt Disease Type 1
11-08-2026
yahoo.com
Belite Bio Inc (BLTE) (Q2 2026) Earnings Call Highlights: FDA Priority Review and Strong Cash ...
14-08-2026
yahoo.com
Belite Bio (BLTE) Stock Looks Fully Valued After A 431% Run
14-08-2026
yahoo.com
Belite Bio (BLTE) Could Be 21% Undervalued On FDA Priority Review News
14-08-2026
yahoo.com
Belite Bio to Host Virtual Commercial Day on September 2, 2026
24-08-2026
yahoo.com
Belite Bio to Participate in Four Upcoming Investor Conferences
01-09-2026
yahoo.com
Belite Bio Wins FDA Priority Review for Tinlarebant in Stargardt Disease
03-09-2026
marketbeat.com
Belite Bio, Inc. Sponsored ADR (BLTE)'s Technical Outlook is Bright After Key Golden Cross
09-09-2026
yahoo.com
What is the current price of BELITE BIO INC - ADR (BLTE:NASDAQ)?
The current price of BELITE BIO INC - ADR (BLTE:NASDAQ) is $173.79.
BELITE BIO INC - ADR (BLTE:NASDAQ) absolute price change since previous trading day?
The absolute price change of BELITE BIO INC - ADR (BLTE:NASDAQ) since the previous trading day is $-1.28.
BELITE BIO INC - ADR (BLTE:NASDAQ) percentage price change since previous trading day?
The percentage price change of BELITE BIO INC - ADR (BLTE:NASDAQ) since the previous trading day is -0.7311%.
What is the most recent average sentiment score for BELITE BIO INC - ADR (BLTE:NASDAQ)?
The most recent average sentiment score for BELITE BIO INC - ADR (BLTE:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for BELITE BIO INC - ADR (BLTE:NASDAQ)?
The most recent sentiment for BELITE BIO INC - ADR (BLTE:NASDAQ) is .
SEC-8K** Filing Available For BELITE BIO INC - ADR (BLTE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.